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Bce-like systems mediate resistance against antimicrobial peptides in Firmicutes bacteria. 25 
Lactobacillus casei BL23 encodes an ‘orphan’ ABC transporter that, based on homology to BceAB-26 
like systems, was proposed to contribute to antimicrobial peptide resistance.  A mutant lacking the 27 
permease subunit was tested for sensitivity against a collection of peptides derived from bacteria, 28 
fungi, insects and humans. Our results show that the transporter specifically conferred resistance 29 
against insect-derived cysteine-stabilized αβ-defensins, and it was therefore renamed DerAB for 30 
defensin resistance ABC transporter. Surprisingly, cells lacking DerAB showed a marked increase in 31 
resistance against the lantibiotic nisin. This could be explained by significantly increased 32 
expression of the antimicrobial peptide resistance determinants regulated by the Bce-like systems 33 
PsdRSAB (formerly Module 09) and ApsRSAB (formerly Module 12). Bacterial two hybrid studies in 34 
E. coli showed that DerB could interact with proteins of the sensory complex in the Psd resistance 35 
system. We therefore propose that interaction of DerAB with this complex in the cell creates 36 
signaling interference and reduces the cell’s potential to mount an effective nisin resistance 37 
response. In the absence of DerB, this negative interference is relieved, leading to the observed 38 
hyper-activation of the Psd-module and thus increased resistance to nisin. Our results unravel the 39 
function of a previously uncharacterized Bce-like orphan resistance transporter with pleiotropic 40 
biological effects on the cell. 41 
IMPORTANCE 42 
Antimicrobial peptides (AMPs) play an important role in suppressing the growth of 43 
microorganisms. They can be produced by bacteria themselves – to inhibit competitors – but are 44 
also widely distributed in higher eukaryotes, including insects and mammals, where they form an 45 
important component of innate immunity. In low GC Gram-positive bacteria, BceAB-like 46 
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transporters play a crucial role in AMP resistance but have so far been primarily associated with 47 
inter-bacterial competition. Here, we show that the orphan transporter DerAB from the lactic acid 48 
bacterium Lactobacillus casei is crucial for high-level resistance against insect-derived AMPs. It 49 
therefore represents an important mechanism for inter-kingdom defense. Furthermore, our 50 
results support a signaling interference from DerAB on PsdRSAB module that might prevent the 51 
activation of a full nisin response. The Bce modules from L. casei BL23 illustrate a biological 52 
paradox where the intrinsic nisin detoxification potential only arises in the absence of a defensin 53 
specific ABC transporter.  54 




Antimicrobial peptides (AMPs) are found in all domains of life and constitute an important 57 
aspect of the natural immune response of many organisms (1, 2). AMPs are considered as an 58 
alternative to classical antibiotics, since the development of resistance has occurred to a lesser 59 
extent (3, 4). One prominent mechanism of action of AMPs is binding to lipid II, leading to the 60 
inhibition of bacterial cell wall biosynthesis, often followed by pore formation with the 61 
concomitant release of cell metabolites and the loss of membrane potential (5-7). Most AMPs are 62 
structurally very diverse, amphipathic molecules composed of 5-60 amino acids with a net positive 63 
charge (http://aps.unmc.edu/AP/main.php (8)). Nisin and subtilin are elongated and flexible, 64 
positively charged type A lantibiotics, while mersacidin is a more globular and rigid type B 65 
lantibiotic with net negative charge (9). Insect AMPs such as cecropins have an α-helical structure, 66 
while defensins have a cysteine-stabilized structure consisting of an N-terminal loop followed by 67 
an α-helix and an antiparallel β-sheet (CSαβ), which are linked by disulfide bridges (10, 11). 68 
Since AMPs represent common threats in microbial habitats, bacteria have developed a 69 
wide range of different AMP resistance mechanisms (3, 12). General or non-specific resistance is 70 
conferred by changing the bacterial surface properties. The dlt (D-alanyl-lipoteichoic acid) operon 71 
mediates the D-alanylation of lipoteichoic and wall teichoic acids (13, 14), while expression of 72 
mprF (“multiple peptide resistance factor”) modifies anionic phospholipids of the membrane with 73 
L-lysine or L-alanine (15, 16). In both cases, the resulting decrease in the net negative charge of 74 
the bacterial envelope reduces the access of cationic AMPs to their surface targets, thereby 75 
conferring resistance. In contrast to this general AMP resistance, ABC transporters constitute 76 
compound-specific resistance determinants for AMP detoxification by actively removing the 77 
peptides from their site of action (17).  78 
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Bce-like systems, named after BceAB from Bacillus subtilis, represent a unique type of 79 
AMP-detoxifying ABC transporters (18, 19). They most likely consist of two nucleotide-binding 80 
domain (NBDs) subunits (ATPases) and a membrane spanning domain (MSD) subunit (permease) 81 
(20) and are functionally and genetically associated with BceRS-like two-component systems (TCS) 82 
(21, 22). The transporter confers resistance by a target-protection mechanism, where constant 83 
removal of the AMP from its cellular target keeps sufficient amounts of lipid II cycle intermediates 84 
available to ensure continued cell wall synthesis (23, 24). The transporter works in a sensory 85 
complex with the histidine kinase (HK), BceS (20). Signaling within this complex is activated in 86 
response to transport activity (25), which is achieved by the transporter directly controlling the 87 
conformational state of the HK (26). Upon activation, BceS then phosphorylates BceR, its cognate 88 
response regulator (RR), which in turn induces the expression of bceAB and sometimes additional 89 
target genes, which ensures antibiotic resistance. Since this detoxification process also removes 90 
the antibiotic from its site of detection (i.e., the transport activity of the resistance transporter 91 
decreases), Bce-dependent signalling is gradually switched off again (25, 26).  92 
So-called ‘dual function’ BceAB-like transporters are required both for sensing the presence 93 
of the AMPs (input) and their detoxification (output). However, a division of labor between Bce-94 
like transporters can be found in some systems: here, a specialized ‘sensing transporter’ perceives 95 
the signal and passes this information on to its cognate TCS, which in turn leads to the expression 96 
of a second ‘resistance transporter’ that removes the AMP from the cell surface (12, 27). 97 
So far, the specificity of BceAB-like transporters could not be correlated with any particular 98 
characteristic feature of the AMPs, such as structure, origin, modification or mechanism of action 99 
(17, 21, 28). Some transporters can confer resistance against structurally very different AMPs, 100 
while at the same time being able to distinguish between very similar compounds. For example, 101 
the Psd system of B. subtilis responds to actagardine and enduracidin but not to mersacidin or 102 
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ramoplanin (29). Intriguingly, BceAB-like transporters can even be induced by AMPs against which 103 
they do not mediate any resistance: e.g. PsdAB is induced by actagardine but does not confer 104 
resistance against it (29). This behaviour indicates that sensing and removal of AMPs are two 105 
separable functions of BceAB-like transporters, an assumption that has been genetically verified 106 
for BceAB of B. subtilis (30). 107 
L. casei BL23 encodes 17 TCSs (31), two of which, TCS09 and TCS12, are homologous to 108 
BceRS from B. subtilis. Both systems are genomically and functionally associated with BceAB-like 109 
transporters, ABC09 and ABC12 respectively, and constitute functional Bce-like units that were 110 
initially referred to as Module 09 and Module 12 (32). Module 09 is a stand-alone detoxification 111 
system, in which ABC09 is a dual function transporter and abc09 is the only known target operon 112 
of RR09. TCS09 responds to nisin via ABC09 and induces the expression of the transporter, which 113 
then confers nisin resistance (Fig. 1). Module 09 additionally confers resistance against bacitracin, 114 
plectasin and subtilin (32). Because its inducer/substrate spectrum and regulatory behaviour 115 
resembles that of PsdRSAB from B. subtilis (29), we renamed Module 09 to PsdRSAB, for peptide 116 
antibiotic sensing and detoxification. For Module 12, ABC12 is a sensing transporter that is not 117 
involved in the detoxification process. In response to nisin, the cognate RR12 instead induces the 118 
expression of a larger regulon that includes the dlt operon, the mprF gene and an operon encoding 119 
an orphan BceAB-like ABC transporter of unknown function (Fig. 1). Module 12 deletion mutants 120 
are sensitive to bacitracin, nisin, subtilin, mersacidin, plectasin and vancomycin, mainly due to the 121 
impaired functionality of the Dlt system, which also renders these mutants acid sensitive (33). This 122 
organisation and behaviour is similar to the Aps system of Staphylococcus epidermidis, which 123 
regulates the expression of the dlt operon, the mprF gene and the vraFG ABC transporter in 124 
response to AMPs (34). We therefore renamed Module 12 to ApsRSAB standing for antimicrobial 125 
peptide sensor.  126 
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In this report, we investigated the function of the ApsR-dependent orphan ABC transporter 127 
from L. casei BL23 in response to AMPs. A mutational study demonstrated that the orphan 128 
transporter is a defensin-specific resistance transporter, which we therefore renamed DerAB, with 129 
DerA (locus LCABL_21680) forming the NBD (ATPase) and DerB (locus LCABL_21670) the MSD 130 
(permease) subunits of the system. Absence of a functional DerAB transporter not only increased 131 
the sensitivity to defensins, but remarkably also resulted in a decreased sensitivity to nisin. This 132 
surprising finding could be explained by gene expression studies in ∆derB mutant showing hyper-133 
activation of the Psd and Aps regulated systems in response to nisin. Moreover, bacterial two-134 
hybrid assays showed that DerB can interact with PsdS and PsdA. Based on these results, we 135 
propose that non-productive protein-protein interactions of DerAB with the PsdRSAB sensory 136 
complex might result in regulatory interference within Psd-module signal transduction that 137 
modulates the induction of the nisin resistance response. 138 
RESULTS  139 
DerAB mediates resistance against insect-derived defensins but renders L. casei nisin sensitive  140 
ApsRSAB from L. casei BL23 is involved in resistance against several bacteriocins and the 141 
fungal peptide plectasin, and it controls the expression of the BceAB-like orphan transporter 142 
DerAB (32), which has so far not been studied with respect to its physiological role. Since all 143 
known BceAB-like transporters mediate AMP resistance (17), we tested the sensitivity of a ΔderB 144 
strain against a wide range of different AMPs. No differences in MIC values were obtained for 145 
bacitracin, mersacidin and vancomycin when comparing the ΔderB strain with the parental strain 146 
BL23 (Table 1). While the absolute MIC values for plectasin (> 40 µg ml-1) and subtilin (3% (v/v)) 147 
were also identical, the derB mutant showed slightly reduced growth in the presence of these 148 
peptides compared to the wild type (Fig. 2A and B, respectively). Surprisingly, the ΔderB strain was 149 
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ten-fold more resistant against nisin than the parental strain (Fig. 2C). Since nisin and subtilin are 150 
structurally similar type A lantibiotics, these results were puzzling. We had previously shown that 151 
PsdAB from BL23 is involved in nisin and subtilin resistance (32), therefore we reasoned that a 152 
contribution to resistance/sensitivity mediated by DerAB should be revealed in a double mutant 153 
ΔderBΔpsdB. For subtilin, we did not observe any significant contribution of DerAB to mediating 154 
resistance (the MIC of subtilin was 0.5% (v/v) for both ΔpsdB and ΔderBΔpsdB). In contrast, the 155 
MIC of nisin was 0.5 µg ml-1 for BL23, 0.3 µg ml-1 for the more sensitive ΔpsdB and 5 µg ml-1 for the 156 
highly resistant strain ΔderB, while the ΔderBΔpsdB mutant had an intermediate phenotype with 157 
an MIC of 1 µg ml-1, being this double mutant more resistant to nisin than the wild type. These 158 
results demonstrate that a derB deletion could rescue the nisin sensitivity of a psdB mutant and 159 
corroborated the relevance of DerAB in the induction of a full nisin resistance response. A more 160 
detailed investigation of the nisin resistance phenotype of ΔderB strain is described below.  161 
Since L. casei strains can be found in the human gastrointestinal tract (35), where it is 162 
exposed to AMPs of the innate immune defence (36), we next tested the sensitivity of the strains 163 
to human AMPs. LL37 is a human cathelicidin (37) that functions as a specific activator of the Bce-164 
like ApeRSAB (formerly YxdJKLM) module of B. subtilis (38, 39), while hBD1 is a human defensin 165 
that is activated by reduction of its disulfide bridges (40, 41). We did not observe any differences 166 
in sensitivity to LL-37 or hBD1 between BL23 and ΔderB strains (Table 1). In contrast, strains 167 
carrying ΔapsR, ΔapsB and ΔdltA mutations were more sensitive to LL-37 than the BL23 wild type 168 
(Fig. S1), indicating a role of ApsRSAB in resistance against LL-37, likely by regulating the activity of 169 
the Dlt system.  170 
Lactobacilli can also be found in the microbiota of insects (42, 43). Next, we tested the 171 
sensitivity of BL23 and ΔderB strains against a collection of 18 insect-derived AMPs. Both strains 172 
were resistant against even the highest concentrations of most insect AMPs tested (Table 1). 173 
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However, for three defensins we could observe significant differences in resistance. The ΔderB 174 
mutant was slightly more sensitive to LSer‐Def4 (BR090, Fig. 2D) and much more sensitive to 175 
sapecin A (BR080; MIC > 160 µg ml-1 for BL23, 80 µg ml-1 for ΔderB) and Lser-Def3 (BR092; MIC > 176 
320 µg ml-1 for BL23, 320 µg ml-1 for ΔderB) (Figs. 2E and F, respectively) than the parental strain, 177 
indicating that DerAB mediates resistance against these compounds.  To confirm that the 178 
observed phenotype was specific to and directly caused by the loss of DerAB, we repeated the 179 
sensitivity experiment for sapecin A on a strain carrying an ectopic copy of derB to complement 180 
the ΔderB mutation. Indeed, complementation restored much of the original resistance (Fig. S2). 181 
The slight remaining differences to the wild type are likely due to altered expression levels of derB 182 
between the native and ectopic copy, as was observed for complementation of a bceB mutant of 183 
B. subtilis (44). Taken together, the data indicate that DerAB specifically mediates resistance 184 
against insect-derived AMPs.  185 
Subsequent microscopic studies revealed significantly different morphological aberrations 186 
in the ΔderB strain when challenged with different AMPs (Fig. 3 and Sup. Table 1). No 187 
morphological differences were found between BL23 and ΔderB strains after exposure to BR005 188 
(Fig. 3C and D), BR081, BR087, BR088, BR091 or subtilin 2% (v/v) (data not shown). In contrast, the 189 
ΔderB strain was strongly affected after exposure to 400 µg ml-1 BR090, showing chaining (Fig. 3J 190 
and K), aberrant morphologies and cells becoming phase transparent (Fig. 3F). Although minor 191 
changes were also observed in the wild type treated with BR090, these were far less pronounced 192 
(Fig. 3E). After incubation with BR080 (Fig. 3G and H) or BR092 (data not shown), the chaining 193 
phenotype of derB deletion mutant was even more pronounced (Fig. 3J and K), whilst the parental 194 
strain remained unaffected. These morphological changes of the ΔderB strain after exposition to 195 
BR080, BR090 and BR092 are in good agreement with the sensitivity phenotypes observed for 196 
these AMPs (Fig. 2). 197 
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L. casei mutants in apsRSAB are defective in D-alanylation of teichoic acids, resulting in a 198 
more negative surface charge and a higher AMP sensitivity of ΔapsR, ΔapsB and Δdlt compared to 199 
the parental strain (32). A possible explanation for the observed sensitivity of the ΔderB strain 200 
could therefore be that DerAB somehow contributes to the regulation of the Dlt system through 201 
ApsRS. However, measurements of the cell surface charge by cytochrome c binding assays (32, 45) 202 
did not show any significant differences between  BL23 and ΔderB strain (Fig. S3), thereby ruling 203 
out this cause for the higher AMP sensitivity of the derB mutant.  204 
Since the ΔderB strain showed the strongest sensitivity phenotypes when exposed to insect-205 
derived defensins (Fig. 2E and F), we additionally investigated the contribution of DerAB to 206 
resistance against crude extracts derived from larvae of the dipteran species black soldier fly 207 
Hermetia illucens (see Materials and Methods for their preparation), which are particularly prolific 208 
sources of broad-spectrum antimicrobial substances (46). A recent transcriptome study identified 209 
53 genes encoding putative AMPs from different families, half of which are putative defensins 210 
(47). Amongst those, the defensin-like peptide 2 (DLP2; 211 
ATCDLLSPFKVGHAACALHCIAMGRRGGWCDGRAVCNCRR) and the defensin-like peptide 4 (DLP4; 212 
ATCDLLSPFKVGHAACAAHCIARGKRGGWCDKRAVCNCRK) have been characterized (48, 49). Both 213 
defensins possess a CSαβ structure and are active against Gram-positive bacteria. If DerAB is a 214 
defensin-specific resistance transporter, its absence should render L. casei also sensitive to 215 
H. illucens extracts. Indeed, the ΔderB strain was over 100-fold more sensitive than the parental 216 
strain (Fig. 2G; MIC is 5 % (v/v) for BL23 and 0.04 % (v/v) for ΔderB), thereby confirming its role in 217 
conferring resistance against AMPs produced by H. illucens. Besides the strong effect on 218 
resistance, we observed some morphological differences in the form of elongated and chaining 219 
cells in the ΔderB strain after exposition to Hermetia larvae extracts (Fig. S4). 220 
11 
 
ApsRSAB regulates different layers of resistance against antibiotics produced by H. illucens 221 
larvae  222 
The AMP resistance determinants of L. casei are controlled by the Psd and Aps modules: 223 
the PsdRSAB system regulates the target operon psdAB, and the ApsRSAB system regulates the 224 
expression of the dlt operon, mprF gene and derAB transporter (32) (Fig. 1). Because of the 225 
potency of the H. illucens larval extracts and the strong difference in sensitivity  between the derB 226 
deletion mutant and the parental strain, we next aimed at analysing the hierarchy within the AMP 227 
resistance network orchestrated by the Psd and Aps modules and the individual contributions of 228 
their target genes to protecting L. casei against the combined challenge of H. illucens extracts. 229 
Towards this goal, we performed a comprehensive mutational study of the individual components 230 
of the AMP resistance network of L. casei (Fig. 4).  231 
The MIC values for strains ΔpsdR and ΔpsdB were similar to that of the wild type strain 232 
BL23 (5% (v/v)), indicating that the stand-alone Psd module is not involved in mediating resistance 233 
against larval extracts (Fig. 4). In contrast, both mutants that rendered the Aps system 234 
dysfunctional, ΔapsR and ΔapsB strains, were highly sensitive to H. illucens extracts, with an MIC 235 
of 0.01% (v/v) (500-fold more sensitive than the wild type).  236 
Next, we determined the MIC for all three Aps-dependent AMP resistance determinants 237 
deleted individually. While both the ΔmprF and ΔdltA mutants showed a slight increase in 238 
sensitivity compared to the wild type, the most marked effect was again observed in the ΔderB 239 
strain (Fig. 4). These data clearly show that the DerAB transporter, provides the primary resistance 240 
layer against the AMPs present in the larval extract, while D-alanylation of teichoic acids and – to a 241 
smaller extent – the L-lysinylation of phospholipids represent a secondary layer of resistance. In 242 
agreement with this hierarchy, the MIC of a ΔderBΔdltA double mutant (0.02% (v/v)) was further 243 
increased compared to the single mutants, that is, 16-fold more sensitive than ΔdltA strain and 2-244 
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fold more sensitive than ΔderB strain. To rule out any minor contributions to resistance by the Psd 245 
system, we also tested a ΔderBΔpsdB double mutant, but could not detect any changes relative to 246 
the ΔderB single mutant. Taken together, our results demonstrate that a clear hierarchical 247 
organization of multiple layers ensure protection of L. casei against insect-derived AMPs, and all 248 
resistance determinants relevant for counteracting the AMPs contained in H. illucens extract are 249 
under control of a single module: ApsRSAB. 250 
Resistance determinant genes are transcriptionally over-expressed in ΔderB strain in response to 251 
nisin. 252 
As mentioned above, the ΔderB strain unexpectedly showed a ten-fold increase in 253 
resistance against nisin (MIC 5 µg ml-1; MIC for parental strain 0.5 µg ml-1) (Table 1 and Fig. 2C). 254 
PsdAB is involved in nisin resistance and partially contributes to the hyper-resistance of ΔderB 255 
(MIC value for double mutant ΔderBΔpsdB of 1 µg ml-1). However, the main nisin resistance 256 
determinant of L. casei is the Dlt system, since the ΔdltA mutant was 12.5-fold more sensitive to 257 
nisin than the wild type (MIC for ΔdltA strain is 0.04 µg ml-1) (32). We have previously shown that 258 
transcription of the psdAB and dltA genes is induced in a nisin-dependent manner in BL23, as are 259 
the genes derAB and mprF (32). We therefore hypothesized that the increased resistance of ΔderB 260 
strain might be due to a higher expression level of the nisin resistance determinants in this 261 
mutant. Thus, we tested the response of these genes following nisin exposure in the ΔderB strain 262 
background compared to the wild type, following the previously established procedure (32).  263 
Expression of psdR, apsB, apsA and apsR was not induced by nisin in either strains (Fig. 5A), 264 
in agreement with the role of PsdRS and ApsRSAB in signaling rather than resistance (32). 265 
Strikingly, nisin exposure of the ΔderB strain led to a notable increase of induction of nisin 266 
resistance genes compared to the BL23 wild type (Fig. 5A): the genes encoding the transporters 267 
(psdA, psdB and derA) were up to ten-fold stronger induced in the ΔderB strain than in the wild 268 
13 
 
type. Likewise, dltA and mprF also responded more strongly (~ 2.5-fold and ~ 3.5-fold, 269 
respectively) in the mutant. Importantly, no significant differences in gene expression were found 270 
between ΔderB and the parental strain in reference conditions (Fig. S5), showing that the 271 
increased induction was due to a hyper-response to nisin exposure and not general changes in 272 
gene expression upon derB deletion. Moreover, since the systems involved in nisin resistance in 273 
L. casei BL23 also mediate subtilin resistance (32), we next tested the response of these genes 274 
following subtilin exposure in the ΔderB strain background compared to the wild type.  Noticeably, 275 
no significant differences in gene expression were found between ΔderB and the parental strain in 276 
response to subtilin (Fig. 5B and Fig. S5). We therefore concluded that the increased nisin 277 
resistance of ΔderB strain was due to an over-expression, compared to the parental strain, of the 278 
nisin resistance determinants psdAB, mprF and the dlt operon, and that this response was specific 279 
for nisin.  280 
DerAB may interfere with signaling through spurious protein-protein interactions. 281 
We next investigated the molecular basis for the observed hyper-induction of nisin resistance 282 
genes in the ΔderB strain. For the BceRSAB system of B. subtilis, it is known that signaling depends 283 
on a sensory complex formed between the transport permease BceB and the histidine kinase BceS 284 
(20). Moreover, signaling requires a functional transporter that is capable of ATP hydrolysis (25, 285 
44), i.e. correct interaction between the permease BceB and the ATPase (BceA) subunits. Since it 286 
could be possible that DerAB may somehow interfere with one or more of the nisin-responsive 287 
signaling pathways in the cell, we performed bacterial two-hybrid experiments of all involved 288 
protein partners to test if the permease DerB is able to interact with any of the components of the 289 
Psd or Aps resistance systems (Fig. 6 and Fig. S6). In addition to the expected interaction between 290 
DerB and DerA, we also obtained positive results for DerB paired with PsdA (Fig. 6). It is possible 291 
that such non-cognate binding of the ATPase PsdA by DerB may reduce the ability of the PsdAB 292 
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transporter to trigger signaling via PsdS. Moreover, we observed clear interactions between DerB 293 
and PsdS (Fig. 6). It is likely that such non-cognate interactions between the permease DerB and 294 
the Psd histidine kinase would interfere with native signaling. Relief of this interference in the 295 
ΔderB strain could then explain the observed increase in the amplitude of the nisin response and 296 
resulting nisin resistance. 297 
Unfortunately, similar bacterial two-hybrid experiments with the Aps proteins were less conclusive 298 
because several of the fusion constructs did not even give positive results with their known 299 
interaction partners (Fig. S6); consequently, these assays were not informative for potential 300 
interactions between DerAB and the Aps system.  301 
DISCUSSION  302 
ABC transporters acting as detoxification mechanisms are of major importance as AMP 303 
resistance systems in Firmicutes (17). In this study, we unraveled the function of DerAB in L. casei 304 
BL23, which belongs to the BceAB-like group of transporters.  305 
Our results demonstrate that from the available panel of antimicrobial compounds, four 306 
CSαβ defensins (plectasin, sapecin A, LSer-Def4 and LSer-Def3) are the most relevant substrates of 307 
DerAB. Such defensins are ubiquitously produced in plants, insects, mussels and fungi and form an 308 
important component of the innate immunity (10). In addition to defined compounds, we also 309 
demonstrated the relevance of DerAB for the survival of L. casei when challenged with a potent 310 
mix of insect AMPs from H. illucens larvae. Lactobacilli grow in a variety of nutrient-rich 311 
carbohydrate-containing habitats. In addition to its well-known roles in fermentation and spoilage 312 
of food, L. casei is also found in the oral cavity, gastrointestinal and genital tracts of humans and 313 
other animals (50). Moreover, different Lactobacillus species have been found in the microbiota of 314 
insects (42, 43). It is usually assumed that lactobacilli present in food come from the food 315 
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processing equipment, raw foodstuffs such as plant material or faecal contamination, but it may 316 
appear that insects may play a role in the dissemination of L. casei. A recent study has provided 317 
evidence suggesting that insects are the natural reservoir of Lactobacillus sanfranciscensis, an 318 
organism involved in sourdough fermentation (51). Interestingly, in this study, Operational 319 
Taxonomic Units (OTUs) belonging to L. casei group were the second most numerous after 320 
L. sanfranciscensis within lactobacilli OTUs (51). Our results suggest that possession of DerAB may 321 
protect L. casei in different AMP-enriched environments of eukaryotic origin, including insects, 322 
and thereby enable it to colonise its hosts. 323 
Furthermore, by testing the sensitivity of our collection of mutants to extracts from 324 
H. illucens larvae, which contain a very potent mixture of AMPs (46, 47), we showed that BL23 325 
possesses several layers of AMP resistance. In this network, DerAB is the defensin-specific primary 326 
resistance mechanism, while the Dlt system and MprF protein constitute the secondary, more 327 
general resistance layer by altering the bacterial surface charge (Fig. 1). Remarkably, in 328 
Bacillus subtilis, the response to bacitracin also consists of a hierarchy of different layers of 329 
resistance: the BceAB transporter constitutes the primary (drug-sensing and highly efficient) 330 
resistance determinant, and the LiaIH system together with the BcrC phosphatase constitute the 331 
secondary (damage-sensing and less efficient) layer of resistance (52). Thus, a clear hierarchical 332 
organization of multiple layers ensure protection of both L. casei and B. subtilis against AMPs. 333 
Interestingly, not only the individual components of the resistance networks are different between 334 
L. casei (DerAB transporter, Dlt operon and MprF protein) and B. subtilis (BceAB transporter, LiaIH 335 
system and BcrC phosphatase) (52), also, the resistance layers are controlled by separate cell 336 
envelope stress systems in B. subtilis (52), whereas all resistance determinants relevant for 337 
counteracting the AMPs contained in H. illucens extract are under control of a single module, 338 
ApsRSAB, in L. casei. 339 
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So far, the substrate specificity of BceAB-like transporters could not be related with any 340 
particular feature of the respective AMPs (17, 21, 28). Our results for DerAB indicated a 341 
preference for CSαβ defensins, e.g. plectasin, sapecin A (BR080), LSer-Def4 (BR090) and LSer-Def3 342 
(BR092). Surprisingly, DerAB does not confer resistance against the structurally closely related 343 
defensins lucifensin (BR088), BR081, BR087, LSer-Def7 (BR089) and LSer-Def6 (BR091) (Table 1). 344 
This indicates that DerAB can distinguish between very similar CSαβ defensin substrates, a 345 
situation reminiscent of the results obtained for the Psd module of B. subtilis (29). We performed 346 
a structural analysis of all tested candidates mentioned above to further investigate this apparent 347 
specificity of DerAB for some defensins (Fig. 7). The investigated defensins show a moderate 348 
sequence conservation with an average sequence identity of 50 % (Fig. S7). The overall structure 349 
of the defensins is well conserved with all available structures harboring a cysteine-stabilized α-350 
helix β-sheet (CSαβ) motif. The main structural deviations are in the N-terminal loop region, which 351 
is also least well conserved, both with respect to its size and amino acid sequence (Fig. 7). No 352 
obvious pattern of structural determinants distinguishing substrates from non-substrates could be 353 
extracted, in line with previous studies on the substrate specificity of BceAB-like transporters (21).  354 
The most puzzling result that we obtained during our initial sensitivity screen was the 355 
hyper-resistance of the derB deletion mutant against the lantibiotic nisin. Transcriptional studies in 356 
the ΔderB strain in response to nisin demonstrated that the absence of this transporter resulted in 357 
an over-induction of mprF, the dlt operon and psdAB. Both the Dlt system and the PsdAB 358 
transporter are crucial for nisin resistance in L. casei (32). Our results strongly suggest that their 359 
over-expression accounts for the hyper-resistance of the ΔderB strain to nisin. This hypothesis is 360 
supported by independent studies in other Firmicutes bacteria that demonstrated the role of dlt 361 
expression levels for AMP resistance. Acquisition of nisin resistance in Lactococcus lactis IL1403 362 
was partly due to higher expression levels of the dlt operon (53). Similarly, strains of 363 
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Staphylococcus aureus Sa113 bearing additional copies of the dlt operon showed an increased 364 
level of D-alanine in LTA and WTA, which led to an increased nisin resistance (45). 365 
In the case of the ΔderB strain investigated here, increased nisin resistance could, however, 366 
not be explained by acquisition of additional copies of resistance genes. Instead, we could show 367 
that DerB has the ability to interact with components of the Psd resistance system. We propose 368 
that such spurious interactions with non-cognate protein partners likely have a negative impact on 369 
signal transduction. That is, in the presence of nisin, not all PsdS histidine kinases receive a signal 370 
from their cognate transporter PsdAB, because a proportion is in a non-productive complex with 371 
DerB. This interference is removed upon derB deletion, allowing the full potential activation of 372 
psdAB expression and thus a greater level of resistance against the AMP. Of note, whereas the 373 
strain C-derB, carrying an ectopic copy of derB in the derB deletion mutant background, 374 
complemented sensitivity to the defensin sapecin A, the restoration of nisin sensitivity was only 375 
very weak (Fig. S2). Likely the ectopic copy of derB did not result in the same protein levels of DerB 376 
in the cell and therefore the interference with normal Psd signaling was not observed. However, 377 
indirect evidence supporting this interference model is available. Results of gene expression 378 
previously reported (32) for mutants defective in the ApsRSAB system, and results reported here 379 
for ∆derB (Fig. 5A and Fig. S5), showed an increase in expression of psdAB in the presence of nisin, 380 
suggesting that a decrease in the ratio of DerAB over PsdAB results in increased PsdRSAB signal 381 
transduction. Furthermore, results obtained with subtilin (Fig. 5B and Fig. S5) show that this is a 382 
nisin-specific effect. To our knowledge, such a negative effect of one Bce-like resistance system on 383 
the function of another has not been previously reported. Also, why this phenotype is observed 384 
with nisin and not with a closely related lantibiotic such as subtilin, is still unclear. 385 
 We previously showed that Bce-like systems are wide-spread among Firmicutes bacteria, 386 
and that many species contain multiple copies with different substrate specificities (21). Often, the 387 
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closest homolog to a given system is found in a different species, while the paralogs within a single 388 
species can be quite distantly related (21). For the Bce-like systems characterized to date, signaling 389 
between transporter and two-component system appears to be highly specific and no accidental 390 
cross-talk has been reported. The example of DerAB reported here may constitute an interesting 391 
evolutionary intermediate where the interaction specificity is not yet completely insulated, 392 
allowing non-productive interference with the Psd system.  In this scenario, in the presence of 393 
nisin, the interference by DerAB should pose a significant fitness burden on the cell. However, we 394 
did not observe any effects of a derB deletion on gene expression when cells were grown in un-395 
challenged reference conditions or after subtilin exposure (Fig.  5B and S5), suggesting that DerAB 396 
has no negative effect in most situations. An alternative scenario could then be that the 397 
interference by DerAB is in fact beneficial to prevent an over-reaction to nisin that could also pose 398 
a fitness burden to the cell. Interestingly, a similar hidden potential in the response to nisin 399 
mediated by Bce-like systems was also previously reported in S. aureus (54). While beyond the 400 
scope of the present study, it would be interesting to investigate if, under suitable experimental 401 
pressure, L. casei BL23 could evolve increased signaling specificity and circumvent the interference 402 
from DerAB. 403 
In summary, in this work we demonstrated that DerAB is a defensin-specific resistance 404 
transporter that constitutes a primary layer of the L. casei cell envelope stress response. Its 405 
expression is controlled by the Aps module that also regulates the secondary, more general, layers 406 
of resistance, the Dlt system and MprF. Given the high degree of protection against insect-derived 407 
AMPs, it appears likely that the physiological role of DerAB is in host-microbe interactions and may 408 
allow L. casei to avoid innate immune defenses to colonise its eukaryotic hosts. 409 
EXPERIMENTAL PROCEDURES: 410 
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Bacterial strains, plasmids and grown conditions 411 
Table 2 and 3 list the strains and plasmids, respectively, used in this study. Escherichia coli 412 
DH10β and Lactococcus lactis MG1363 were used as intermediate hosts for cloning purposes. 413 
E. coli strains were grown in LB medium at 37°C with aeration. L. lactis strains were grown in M17 414 
medium supplemented with 0.5 % (w/v) glucose at 30°C under static conditions. L. casei strains 415 
were grown in MRS broth (Oxoid) at 37°C under static conditions. 1.5 % (w/v) agar was added to 416 
prepare the corresponding solid media. Strains were stored at -80°C in their corresponding growth 417 
media containing 20 % (v/v) glycerol. Ampicillin 100 µg ml-1 was added to E. coli, and erythromycin 418 
5 µg ml-1 was added to L. lactis and L. casei, when required. 419 
Construction of mutants 420 
Oligonucleotides used in this study are listed in Table 4. Cloning in E. coli was performed 421 
following standard methods (55). E. coli strains were transformed by electroporation with a Gene 422 
Pulser apparatus (Bio-Rad), as recommended by the manufacturer; L. lactis strains were 423 
transformed by electroporation (56) and L. casei strains were transformed as described previously 424 
(57). 425 
For a complete deletion of gene LCABL_21670 (ΔderB) from L. casei BL23, two DNA 426 
fragments of approximately 700 bp upstream and downstream of the target gene were amplified 427 
from genomic DNA using primers pairs RG062-063 and RG064-065 (see Table 4). All subsequent 428 
steps of mutant construction were performed as previously described (32). Strain C-derB with the 429 
complementation of the derB deletion was achieved by cloning the corresponding gene and 430 
potential ribosome binding site (12 pb intergenic region between derA-derB), with primer pair 431 
RG220-221 (SpeI and BglII restriction sites; Table 4), under the constitutive P1 promoter in the 432 
expression vector pT1NX (58). The resulting plasmid pT1-RBSderBderB (Table 3) was used to 433 
transform L. lactis MG1363, and transformants were checked by sequencing of the inserted 434 
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fragment.  Subsequently, plasmid pT1-RBSderBderB was used to transform L. casei ∆derB, resulting 435 
in strain L. casei C-∆derB (Table 2) which was maintained with erythromycin selection.  436 
Double mutant strains ΔderBΔdltA and ΔderBΔpsdB were obtained by insertional 437 
inactivation of genes LCABL_08550 (dltA) and LCABL_16400 (psdB), respectively, in L. casei ΔderB 438 
mutant background. A procedure similar to the previously described to obtain insertionally 439 
inactivated single mutants of genes LCABL_08550 and LCABL_16400 was followed (32).  440 
Bacterial two-hybrid assays 441 
We constructed C-terminal and N-terminal translational fusions of the T18 and T25 442 
domains of the adenylate cyclase CyaA of Bordetella pertussis for each protein individually (40 443 
constructs; Table 3), to test protein-protein interactions between DerAB and PsdRSAB module, 444 
and between DerAB and ApsRSAB module. Fusions were tested in pairwise combinations in E. coli 445 
BTH101 (59). For each co-transformation mixture, 3 times 10 μl were spotted onto LB agar plates 446 
containing 1 mM isopropyl-β-D-1-thio-galactopyranoside (IPTG) and 100 μg ml-1 5-bromo-4-chloro-447 
3-indolyl-β-D-galactopyranoside (X-Gal) with selection for ampicillin and kanamycin resistance. 448 
Plates were incubated at 30 °C for 48 h. Positive interaction results were identified by the 449 
formation of blue colonies.  450 
Source or preparation of eukaryotic AMPs and subtilin  451 
HBD-1 and LL-37 were purchased from Sigma-Aldrich™ (SRP3011 and 94261, respectively) 452 
and were reconstituted according to manufacturer instructions. The insect AMPs shown in Table 1 453 
were selected according to their reported structural and functional properties, synthesized and 454 
purified to >95%. Cecropin 1 (from Eristalis) was synthesized by PepMic (Pepmic Suzhou, Jiangsu, 455 
China). Cecropin A (from Hyalophora and Aedes), Stomoxyn (from Stomoxys) and Sarcotoxin IA 456 
were synthesized by JPT (JPT Peptide Technologies GmbH, Berlin, Germany). The rest of the 457 
peptides were synthesized by Covalab (Covalab S.A.S., Villeurbanne, France), based on the 458 
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sequence of the mature peptides. All peptides were lyophilized for storage and were resuspended 459 
and diluted in double-distilled water. Excluding Aedes and Eristalis cecropins, all other cecropins 460 
and Stomoxys stomoxyn were modified by the C-terminal amidation. 461 
Larvae of the black soldier fly (Hermetia illucens) were obtained from a pilot rearing plant 462 
in Grimma, Saxony, Germany, and grown at 24°C in the laboratory. H. illucens larvae were induced 463 
as previously described (39, 46) by injecting a fungal spore suspension (spores of 464 
Verticillium lecanii and Metarhizium anisopliae) into the haemolymph and by feeding a bacterial 465 
mix (E. coli, Micrococcus luteus, Pseudomonas fluorescens, B. subtilis) to simulate an infection and 466 
boost AMP production. The larvae were pricked as previously described (46). Aqueous larval 467 
extract from H. illucens was prepared as previously described (46) and was considered to be at a 468 
concentration of 100% (v/v) for the MIC assays.  469 
B. subtilis ATCC 6633 was grown in medium A to induce subtilin production as in (60). 470 
Culture supernatant was collected and was considered to be at a concentration of 100% (v/v) for 471 
MIC assays.  472 
Antibiotic sensitivity testing  473 
MIC assays were performed in 96-well microtiter plates as previously described (32). 474 
Overnight cultures of the strains under study were prepared with antibiotic selection when 475 
required but, no antibiotic was added for the MIC assays. The 96-well plates were incubated at 476 
37°C under static conditions in a SynergyTM NEOALPHAB multi-mode microplate reader (BioTek®, 477 
Winooski, VT, USA). Growth was monitored by changes in OD595. For each strain, the MIC at 15 h 478 
was defined as the lowest antibiotic concentration where the final OD was at or below the starting 479 
OD. All experiments were performed at least in duplicate.  480 
Microscopy  481 
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Stationary phase cell cultures assessed in MIC assays were photographed. Morphology of 482 
cultures grown for 24 h in MRS was taken as reference. Possible morphological changes on 483 
bacteria were checked after exposition for 24 h to BR005, BR080, BR081, BR087, BR088, BR090, 484 
BR091, BR092, subtilin and H. illucens larval extracts. The cells were observed in an Olympus AX70 485 
microscope with phase contrast at 40x magnification. Pictures were taken with an Olympus U-486 
TV1XC camera. Pictures were analysed using the tools implemented in the Olympus Cells Sens 487 
Dimensions 1.14 software and Corel Photo Paint X5. 488 
The average cell length of the bacteria (n = 200),  the average cell-chains length (n = 40 cell-chains) 489 
and the average number of cells per chain (n = 40 cell-chains) of the stationary phase cell cultures 490 
photographed were determined using the tools implemented in the ImageJ 1.52i software  (61). 491 
Unpaired t-tests (two-tailed P value, 95% confidence intervals) comparing the values of BL23 and 492 
∆derB under the reference condition indicated means significantly different (P<0.05) for the cell-493 
chains length (P value= 0.023) and the number of cells per chain (P value= 0.002). To determine 494 
whether the morphological phenotypes of the mutant strain upon exposition to each insect 495 
derived AMP assayed were significantly different from that of the wild type, pairwise two-way 496 
ANOVA analyses were run with GraphPad Prism 5 software, testing the values of both strains 497 
under the reference condition and after each AMP exposition. A significant difference was 498 
considered when the analysis estimated P values were below of 0.01. 499 
Cytochrome c binding assay 500 
Comparison of the whole-cell surface charge of the wild-type strain and mutant ΔderB was 501 
performed by a cytochrome c binding assay as in (32). Briefly, cells in stationary phase at 1010 502 
CFU ml-1 were incubated with 150 µg ml-1 cytochrome c (Sigma) in 20 mM MOPS 503 
(morpholinepropanesulfonic acid), pH 7, for 10 min at room temperature. The mixture was 504 
centrifuged twice, and the absorbance of the supernatant (containing unbound cytochrome c) was 505 
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determined at 530 nm. The binding ratio was calculated by comparing the absorbance of each 506 
supernatant after incubation with the cells relative to the absorbance of the cytochrome c solution 507 
without bacterial cells. 508 
Antimicrobial peptide information and structure predictions 509 
The Antimicrobial Peptide Database (APD) (http://aps.unmc.edu/AP/main.php) (8) was 510 
used as a reference for the information listed in Table 1. For structural information the Protein 511 
Data Bank (www.rcsb.org) (62) or UniProt (http://www.uniprot.org/) (63) were used. The 512 
structures of Plectasin (PDB ID 1ZFU (64)), BR080 (sapecin A; PDB ID 1L4V (65)) and BR088 513 
(lucifensin, PDB ID 2LLD (66)) were used. If no structure was available, the Swiss-Model webpage 514 
was used to generate structural predictions (https://swissmodel.expasy.org/) (67-70). The 515 
structures of BR081, BR087, BR089, BR090, BR091 and BR092 were modelled applying the 516 
Sapecin A structure (PDB: 1L4V) as template. Structural comparison was performed with YASARA 517 
View (www.yasara.org) program. Multiple sequence alignment of the defensins was performed 518 
with the CLC Main Workbench 7.7.3 program.  519 
Reverse-transcription and quantitative real-time PCR (qRT-PCR) 520 
Samples for RNA isolation were collected as previously described (32). Nisin 22.5 ng ml-1 521 
and subtilin 1 % were used for the induction assays. Isolation of total RNA from L. casei strains, 522 
synthesis of cDNA, primer design and qRT-PCR were carried out as described previously (71). 523 
Primers used are listed in Table 4. lepA, ileS, pyrG and pcrA were used as constitutive reference 524 
genes (71). Linearity and amplification efficiency for each primer pair were previously determined 525 
(32). The relative expression based on the expression ratio between the target genes and 526 
reference genes was calculated using the software tool REST (72). Every real-time PCR 527 
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TABLES  741 









Bacitracin  cyclic peptide n. r.  ICLEIKOrnIFHDN d (bond between Lys6 and Asn12)  cyclic 10 10 
Nisin A type A 
lantibiotic 
AP00205 ITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK non-αβ 0.5 5 
Mersacidin type B 
lantibiotic 
AP01206 CTFTLPGGGGVCTLTSECIC non-αβ 10 10 
Subtilin type A 
lantibiotic 
AP00206 WKSESLCTPGCVTGALQTCFLQTLTCNCKISK unknown 3c 3c (¶) 




Plectasin  defensin AP00549 GFGCNGPWDEDDMQCHNHCKSIKGYKGGYCAKGGFVCKCY combine-αβ >40 >40 (¶) 
Insect AMPs 
BR001 Cecropin A cecropin  AP00139 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK*-NH2 α >320 >320 
BR002 Sarcotoxin IA cecropin A2 AP00230 GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR*-NH2 α >320 >320 
BR003 Cecropin A (insect: Aedes 
aegypti) 
cecropin  n.r. GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKALRK (α) >320 >320 
BR005 Stomoxyn stomoxyn AP00484 RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAGSGAAVVAAT α >320 >320 
BR044 LSerStomox2 stomoxyn AP02513 GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG (α) >320 >320 
BR080 Sapecin A defensin AP00227 ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKAVCVCRN combine-αβ >160 80 
BR081 (insect: Aeschna cyanea) defensin AP00182 GFGCPLDQMQCHRHCQTITGRSGGYCSGPLKLTCTCYR bridge >320 >320 
BR087 (insect: Lucilia sericata) defensin n. r.  ATCDLLSATGFSGTACAAHCLLIGHRGGYCNTKSVCVCRD (combine-αβ) >400 >400 
BR088 Lucifensin defensin AP01532 ATCDLLSGTGVKHSACAAHCLLRGNRGGYCNGRAICVCRN combine-αβ >400 >400 
BR089 LSer-Def7 defensin AP02507 FTCNSYACKAHCILQGHKSGSCARINLCKCQR bridge >320 >320 
BR090 LSer-Def4 defensin AP02505 LTCNIDRSFCLAHCLLRGYKRGFCTVKKICVCRH bridge >400 >400 
(¶) 
BR091 LSer-Def6 defensin AP02506 GTCSFSSALCVVHCRVRGYPDGYCSRKGICTCRR bridge >400 >400 
BR092 LSer-Def3 defensin AP02504 ATCDLLSGTGANHSACAAHCLLRGNRGGYCNSKAVCVCRN bridge >320 320 
BR097 Cecropin A (Galleria 
mellonella) 
cecropin AP03067 KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG*-NH2 (α) >320 >320 
BR098 Cecropin B (G. mellonella) cecropin AP03068 KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK*-NH2 (α) >320 >320 
BR099 Cecropin C (G. mellonella) cecropin AP03069 RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG*-NH2 (α) >320 >320 
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a Antimicrobial Peptide Database (APD3) (8) identification number. n.r., not registered in APD3; n.f., not found. b3D structure as annotated in 743 
APD3 based in (73): α, AMPs with helical structures; combine-αβ, AMPs with α-helical and β-strands in the 3D structure; non-αβ, contains neither 744 
α-helical nor β-strands; bridge, AMPs without 3D structure determined, disulfide-linked, usually β-structure. When no structural data was 745 
available, structure prediction was made using the Swiss-Model webpage (https://swissmodel.expasy.org/) (67) and is indicated in parenthesis. 746 
cMIC in µg ml-1 except for: subtilin (% (v/v)) and vancomycin (mg/ml). (¶) indicates that the mutant is more sensitive when assays for final cell 747 
densities (see Fig. 2). d Sequence of linear peptide precursor.748 
BR100 Gm cecropin D-like pept cecropin D  AP00755 ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD*-NH2 (α) >320 >320 
BR101 Et-Cec1 (Eristalis tenax) cecropin  n. r. GFLKKIGKKLEGAVQRTRDATIQTIAVAQAAANVAATAKQG (α) >320 >320 
Human AMPs  
LL37  cathelicidin AP00310 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES α-helix >27 >27 
hBD-1  defensin AP00451 DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK combine-αβ >20 >20 
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TABLE 2. Bacterial strains used in this study 749 
Strains  Descriptiona Source or 
reference 
E. coli DH10β F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 ΔlacX74 endA1 
recA1 deoR Δ(ara,leu)7697 araD139 galU galK nupG rpsL λ- 
Stratagene 
E. coli BTH101 F-, cya-99, araD139, galE15, galK16, rpsL1 (Str r), hsdR2, 
mcrA1, mcrB1. 
Lab collection 
L. lactis MG1363 Plasmid-free derivative of NCDO712 (74) 
L. casei BL23 Wild type B. Chassy, U. 
Illinois 
L. casei ΔpsdR BL23 ΔLCABL_16430 (32) 
L. casei ΔapsR BL23 Δrrp1 (LCABL_19600) (31) 
L. casei ΔderB BL23 ΔLCABL_21670 This study 
L. casei C-ΔderB BL23 ΔLCABL_21670 harbouring plasmid pT1-RBSderBderB Eryr This study 
L. casei ΔpsdB LCABL_16400 mutant; pRV16400 Eryr (32) 
L. casei ΔapsB LCABL_19580 mutant; pRV19580 Eryr (32) 
L. casei ΔdltA LCABL_08550 (dltA) mutant; pRV08550 Eryr (32) 
L. casei ΔmprF LCABL_24490 mutant; pRV24490 Eryr (32) 
L. casei 
ΔderBΔpsdB 
BL23 ΔLCABL_21670; LCABL_16400 mutant, pRV16400 Eryr This study 
L. casei 
ΔderBΔdltA 
BL23 ΔLCABL_21670; LCABL_08550 (dltA) mutant, pRV08550 
Eryr  
This study 
a Ampr, ampicillin resistance; Eryr, erythromycin resistance; Strr, streptomycin resistance. 750 
  751 
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TABLE 3. Vectors and plasmids used in this study 752 
Vector or 
plasmid 
Descriptiona Source or reference 
pRV300 Insertional vector for Lactobacillus, Ampr, Eryr (75) 
pT1NX Expression vector for Gram-positive bacteria harboring the 
constitutive P1 promoter; Eryr 
(58) 
pRVOrPe-del pRV300 containing fused flanking fragments upstream and 
downstream of LCABL_21670 
This study 
pRV08550 pRV300 containing a 679-pb internal fragment of 
LCABL_08550 (dltA) 
(32) 
pRV16400 pRV300 containing a 975-pb internal fragment of 
LCABL_16400 (psdB) 
(32) 
pT1-RBSderBderB pT1NX with cloned LCABL_21670 (derB) and its ribosome 
binding site (derA-derB 12 pb intergenic region) 
This study 
pUT18  Vector for B2H, Ampr 
Euromedex, BACTH 
System Kit Manual 
pUT18C Vector for B2H, Ampr 
pUT18C zip  Control plasmid for B2H, Ampr 
pKT25 Vector for B2H, Kanr 
pKNT25 Vector for B2H, Kanr 
pKT25 zip  Control plasmid for B2H, Kanr 
pUT18C-HK9 pUT18C containing histidine kinase psdS LCABL_16420 This study 
pKT25-HK9 pKT25 containing histidine kinase psdS LCABL_16420 This study 
pU-HK9-T18 pUT18 containing histidine kinase psdS LCABL_16420 This study 
pKN-HK9-T25 pKNT25 containing histidine kinase psdS LCABL_16420 This study 
pUT18C-RR9 pUT18C containing response regulator psdR LCABL_16430 This study 
pKT25-RR9 pKT25 containing response regulator psdR LCABL_16430 This study 
pU-RR9-T18 pUT18 containing response regulator psdR LCABL_16430 This study 
pKN-RR9-T25 pKNT25 containing response regulator psdR LCABL_16430 This study 
pUT18C-Per9 pUT18C containing permease psdB LCABL_16400 This study 
pKT25-Per9 pKT25 containing permease psdB LCABL_16400 This study 
pU-Per9-T18 pUT18 containing permease psdB LCABL_16400 This study 
pKN-Per9-T25 pKNT25 containing permease psdB LCABL_16400 This study 
pUT18C-ATP9 pUT18C containing ATPase psdA LCABL_16410 This study 
pKT25-ATP9 pKT25 containing ATPase psdA LCABL_16410 This study 
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pU-ATP9-T18 pUT18 containing ATPase psdA LCABL_16410 This study 
pKN-ATP9-T25 pKNT25 containing ATPase psdA LCABL_16410 This study 
pUT18C-HK12 pUT18C containing histidine kinase apsS LCABL_19610 This study 
pKT25-HK12 pKT25 containing histidine kinase apsS LCABL_19610 This study 
pU-HK12-T18 pUT18 containing histidine kinase apsS LCABL_19610 This study 
pKN-HK12-T25 pKNT25 containing histidine kinase apsS LCABL_19610 This study 
pUT18C-RR12 pUT18C containing response regulator apsS LCABL_19600 This study 
pKT25-RR12 pKT25 containing response regulator apsS LCABL_19600 This study 
pU-RR12-T18 pUT18 containing response regulator apsS LCABL_19600 This study 
pKN-RR12-T25 pKNT25 containing response regulator apsS LCABL_19600 This study 
pUT18C-Per12 pUT18C containing permease apsB LCABL_19580 This study 
pKT25-Per12 pKT25 containing permease apsB LCABL_19580 This study 
pU-Per12-T18 pUT18 containing permease apsB LCABL_19580 This study 
pKN-Per12-T25 pKNT25 containing permease apsB LCABL_19580 This study 
pUT18C-ATP12 pUT18C containing ATPase apsA LCABL_19590 This study 
pKT25-ATP12 pKT25 containing ATPase apsA LCABL_19590 This study 
pU-ATP12-T18 pUT18 containing ATPase apsA LCABL_19590 This study 
pKN-ATP12-T25 pKNT25 containing ATPase apsA LCABL_19590 This study 
pUT18C-OrPe pUT18C containing permease derB LCABL_21670 This study 
pKT25-OrPe pKT25 containing permease derB LCABL_21670 This study 
pU-OrPe-T18 pUT18 containing permease derB LCABL_21670 This study 
pKN-OrPe-T25 pKNT25 containing permease derB LCABL_21670 This study 
pUT18C-OrATP pUT18C containing ATPase derB LCABL_21680 This study 
pKT25-OrATP pKT25 containing ATPase derB LCABL_21680 This study 
pU-OrATP-T18 pUT18 containing ATPase derB LCABL_21680 This study 
pKN-OrATP-T25 pKNT25 containing ATPase derB LCABL_21680 This study 
a Ampr, ampicillin resistance; Eryr, erythromycin resistance; Kanr, kanamycin resistance. 753 
 754 
 755 
  756 
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Table 4. Primers used in this study 757 
Primer  Gene Sequence (5´- 3´) a 
Cloning 
RG037 LCABL_08550 AGTCAAGCTTGTTCAGATTATTCGCGCACC 
RG038 LCABL_08550 GACTACTAGTCTGACACTTGATTGCCTTGC 
RG047 LCABL_16400 CTATAGGGCGAATTGGGTACCGCAAGCCTTCAGTATCGCCG 
RG048 LCABL_16400 CTCGAGGGGGGGCCCGGTACCTCAGCCGCGTTTTGATAGCG 
RG062 LCABL_21680 TTTTCTCGAGTCAGGTTCAGGGAAAACGAC 
RG063 LCABL_21680 GTGCGACCTAAAGGATCTTTTCTAGACGACGCCCCTTACTTTTG 





RG065 LCABL_21660 AAAAGAATTCCGCCTCAAAAGACTTCATGC 
RG220 LCABL_21670 AAAAACTAGTTTAGGCTTTTTCCGCTAAGTTCTTATTG 
RG221 LCABL_21670 AAAAAGATCTGGGGCGTCGTCTATGTTAACG 
Cloning checking 
pRV300.fw pRV300 vector GTTTTCCCAGTCACGAC 
pRV300.rv pRV300 vector CAGGAAACAGCTATGAC 
pT1NX.fwd pT1NX vector TGGATTGGATTAGTTCTTGTGG 
pT1NX.rev pT1NX vector CTTCTCTGTCGCTATCTGTTG 
RG068 LCABL_21660 TATGAAGTCGGCTTCCCGCATG 
RG069 LCABL_21680 GTGAATTCGTCGGCATCATG 
RG076  LCABL_21680 AACACCCGCATTGAAAGGTG 
RG077 LCABL_21660 TCAGCAAAAACGTCACTGGC 
LSEI1418R LCABL_16410 GTCAACATTACTTAAATTAAAAA 
qRT-PCR 
lepA-F lepA CACATTGATCACGGGAAGTC 
lepA-R  lepA GTAATGCCACGTTCACGTTC 
ileS-F  ileS ACCATTCCGGCTAACTATGG 
ileS-R  ileS TCAGGATCTTCGGATTTTCC 
pcrA-F  pcrA CGGCCAATAATGTGATTCAG 
pcrA-R  pcrA TCATCAGTTTCGCTTTGAGC 
pyrG-F  pyrG AATTGCGCTTTTCACTGATG 
pyrG-R  pyrG CGAAATGATCGACCACAATC 
RG006 LCABL_19580 GGGAACGCGCATTCATTGTG 
RG007 LCABL_19580 TCTCGCGCTGAACAAGATCC 
RG008 LCABL_21670 TTGCCGGTATTTTGGTCGGG 
RG009 LCABL_21670 ATGTCCACAATACGGCTGGC 
RG019 LCABL_08550 TGGTCGAGGTTTTCTTGGGC 
RG020 LCABL_08550 CCGGTGTATGGGCAACATCC 
RG021 LCABL_24490 GCCGGATCAGCCAAGACTTG 
RG022 LCABL_24490 TTAGCATCGGTGTAACGGCG 
RG027 LCABL_19590 TAGCTTTCAGGTCAACGCGG 
RG028 LCABL_19590 CTTGGCGTCTCAATCGTTGC 
RG029 LCABL_19600 GGCAATGAATATGGGCGCTG 
RG030 LCABL_19600 TAGGTTCGTCGAAGCAAGGC 
RG031 LCABL_21680 CACCCGCATTGAAAGGTGTC 
RG032 LCABL_21680 GCAAGGTCGTTTTCCCTGAAC 
RG033 LCABL_16410 GGACAGGATCTGAGCAACGTC 
RG034 LCABL_16410 ATTGAAGGTGTCAAGCAAGTCG 
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RG054 LCABL_16400 GTACCGTCCTTTCCCGCATC 
RG055 LCABL_16400 CCGATGGTAATGATCCCGGC 
RG056 LCABL_16430 AGCGAGTTACGCAAACACAG  
RG057 LCABL_16430 CGGCTCCTAAGTTCATCGCC  
B2H 
TM1220 pUT18 fwd AGCTCACTCATTAGGCACCC 
TM1221 pUT18 rev CCGTCGTAGCGGAACTGGCG 
TM1222 pUT18C fwd TCGACGATGGGCTGGGAGCC 
TM1223 pUT18C rev AGCAGACAAGCCCGTCAGGG 
TM1224 pKT25 fwd GGCGGATATCGACATGTTCG 
TM1225 pKT25 rev ATCGGTGCGGGCCTCTTCGC 
TM1226 pKT25N fwd GCTCACTCATTAGGCACCCC 
TM1227 pKT25N rev GGCGGAACATCAATGTGGCG 
TM5702 HK9-B2H-XbaI.fw1 AAAATCTAGAGATGATGAAAGCTTATTGCCGCTCG 
TM5703 HK9- B2H-SmaI.rv1 AAAACCCGGGTTACTCCACTTGCCACCGCG 
TM5704 HK9-B2H-SmaI.rv2 AAAACCCGGGGCTCCACTTGCCACCGCGTTTG 
TM5705 RR9-B2H-XbaI.fw1  AAAATCTAGAGATGGCACAGAAAATTTTTATTGTCGAAG 
TM5706 RR9-B2H-SmaI.rv1 AAAACCCGGGTCATGGCTTTGGTCCCTCAC 
TM5707 RR9-B2H-SmaI.rv2 AAAACCCGGGGTGGCTTTGGTCCCTCACTTGC 
TM5708 ATP9-B2H-XbaI.fw1 AAAATCTAGAGATGTCAACATTACTTAAATTAAAAAATATCGA
AAAAAC 
TM5709 ATP9-B2H-BamHI.rv1 AAAAGGATCCTCTCATTGTCCATCGCCTGCCTTTG 
TM5710 ATP9-B2H-BamHI.rv2 AAAAGGATCCTCTTGTCCATCGCCTGCCTTTG 
TM5711 Per9-B2H-XbaI.fw1 AAAATCTAGAGATGAAATTCTACTTTAAGCTCGCTGC 
TM5712 Per9-B2H-SmaI.rv1 AAAACCCGGGTTAGCTGCGACTGGTAGCTTGG 
TM5713 Per9-B2H-SmaI.rv2 AAAACCCGGGGGCTGCGACTGGTAGCTTGGC 
TM6396 HK12-B2H-XbaI.fw1 AAAATCTAGAGATGCGGTTTCGTGATTATTTAAAGG 
TM6397 HK12-B2H-SmaI.rv1 AAAACCCGGGTCAGCTGTCTGGATGTGACCTAG 
TM6398 RR12-B2H-XbaI.fw1 AAAATCTAGAGGTGTTTAAAATCATGATCGTAGAGG 
TM6399 RR12-B2H-SmaI.rv1 AAAACCCGGGCTAAGGAACGATGTAACCTTGTC 
TM6400 P12-B2H-XbaI.fw1 AAAATCTAGAGGTGGAGGAGGCCATACCCGTG 
TM6401 P12-B2H-SmaI.rv1 AAAACCCGGGCTAATCAATCGCCCAACGGGAAAC 
TM6402 A12-B2H-XbaI.fw1 AAAATCTAGAGATGGCAATTCTTGAAGTATCTAACTTGAG 
TM6403 A12-B2H-SmaI.rv1 AAAACCCGGGTTAATCAGATGCCACACGGG 
TM6404 OrPe-B2H-XbaI.fw1 AAAATCTAGAGATGTTAACGAAACTTGCACTCGG 
TM6405 OrPe-B2H-BamHI.rv1 AAAAGGATCCTTAGGCTTTTTCCGCTAAGTTCTTATTG 
TM6406 OrA-B2H-XbaI.fw1 AAAATCTAGAGATGGACAAGCAACCTGTCGTAAC 
TM6407 OrA-B2H-BamHI.rv1 AAAAGGATCCTTACTTTTGAAATGTGCCGAGTGTG 
TM6408 HK12-B2H-SmaI.rv2 AAAACCCGGGGGCTGTCTGGATGTGACCTAGTCTG 
TM6409 RR12-B2H-SmaI.rv2 AAAACCCGGGGAGGAACGATGTAACCTTGTCC 
TM6410 P12-B2H-SmaI.rv2 AAAACCCGGGGATCAATCGCCCAACGGGAAACAG 
TM6411 A12-B2H-SmaI.rv2 AAAACCCGGGGATCAGATGCCACACGGGTATG 
TM6412 OrPe-B2H-BamHI.rv2 AAAAGGATCCTCGGCTTTTTCCGCTAAGTTCTTATTG 
TM6413 OrA-B2H-BamHI.rv2 AAAAGGATCCTCCTTTTGAAATGTGCCGAGTGTG 
a Restriction sites are underlined. Sequences highlighted in boldface type are the sequences for 758 
the CloneEZ PCR reaction as in reference (32). 759 





Figure 1: Different layers of resistance against AMPs in L. casei BL23. 763 
ApsRSAB is a sensory module that regulates different layers of resistance against numerous AMPs. 764 
The primary layer of AMP resistance is mediated by DerAB (drug transport) and the secondary 765 
layer of resistance is mediated by the Dlt-system and MprF protein (drug repulsion). Resistance 766 
mediated by DerAB is specific for defensins and – to a lesser degree - lantibiotics (see text for 767 
details). PsdRSAB is a dual-function module involved in sensing and transport of various AMPs. 768 
AMPs are depicted as red positively charged starts. S, histidine kinase; R, response regulator; B, 769 
permease; A, ATPase. Homodimers of HKs and RRs are indicated. ABC transporters are composed 770 
of a permease subunit and two ATPase domains (20). Signaling between the permeases and the 771 
HKs and between the HKs and the RRs is indicated by black solid arrows. Gene activation and the 772 
increased production of the transporters is indicated by black dash-dot arrows. Wave-shaped, 773 
downward red arrows indicate sensing of AMPs; blue up-facing arrows indicate transport and 774 
detoxification. B2H protein-protein interactions of DerB with PsdRSAB are indicated with purple 775 
dotted lines. Lipoteichoic acids are indicated with grey negatively charged lines; D-alanylation of 776 
teichoic acids and L-lysinilation of membrane phospholipids is indicated with positive red-filled 777 
spheres; AMP charge-repulsion is indicated with a bar-headed up-facing blue line.  778 




Figure 2: MIC of different AMPs for L. casei BL23 (white squares) and ΔderB strains (black 781 
circles). (A) Plectasin. (B) Subtilin. (C) Nisin. (D) LSer-Def4 (BR090). (E) Sapecin A (BR080). (F) LSer-782 
Def3 (BR092). (G) Extract from H. illucens larvae. Strains were inoculated to an OD595 of 0.05 783 
(dashed line) in MRS with different concentrations of antibiotics.  Final OD595 readings were taken 784 
after 15h incubation at 37°C (OD595 15h). MIC (see Table 1) was defined at the lowest antibiotic 785 
concentration where the final OD was at or below the starting OD. Mean and standard deviation 786 
are presented of at least duplicates. A representative result of H. illucens extract is presented 787 
because due to the preparation procedure, the absolute potency of each extract (as expressed in 788 
%) varies significantly between individual preparations, but the relative sensitivities were very well 789 
reproduced in independent assays. 790 




Figure 3: Sensitivity phenotypes of ΔderB strain are associated to morphological changes.  793 
(A - H) Microscopic characterization after AMP exposition: stationary phase cell cultures of BL23 794 
(left column pictures) and ΔderB (right column pictures) grown for 24 hours under reference 795 
conditions (A and B) or in the presence of insect derived AMPs were photographed (phase 796 
contrast, 40x magnification). Selected AMPs were chosen as representative of different 797 
sensitivities of the ΔderB strain relative to the wild type (see Table 1). Similar sensitivity 798 
phenotype: BR005 at 320 µg ml-1 (C and D). ΔderB slightly more sensitive than BL23: BR090 at 400 799 
µg ml-1 (E and F). Mutant much more sensitive than wild type: BR080 at 80 µg ml-1 (G and H). Scale 800 
bar 10 µm. 801 
(I - K) Quantification of the morphological changes associated to the sensitivity phenotypes.  802 
(I)The average bacterial length (µm; n = 200), (J) the average cell-chains length (µm; n = 40 cell-803 
chains) and (K) the average number of cells per chain (n = 40 cell-chains) of the stationary phase 804 
cell cultures photographed in (A - H) were determined. BL23 and ΔderB are depicted with blue and 805 
red circles, respectively. Means and standard deviations are indicated with the horizontal and the 806 
bar-headed vertical black lines, respectively. For a detailed statistical analysis of the results see 807 
Supplemental Table 1.  808 
 809 




Figure 4: Different layers of resistance against AMPs from H. illucens. MIC at 15h (expressed as 812 
% (v/v) of initial extract) of H. illucens larvae extract against L. casei BL23 and derivative strains. A 813 
representative dataset is shown. Due to the preparation procedure, the absolute potency of each 814 
extract (as expressed in %) vary significantly between individual preparations, but the overall 815 











Figure 5: Expression of known AMP resistance determinants in L. casei BL23 and ΔderB mutant 825 
after nisin (A) and subtilin (B) addition. Transcript levels were determined by real-time RT-PCR 826 
10 min after addition of 22.5 ng ml-1 nisin (A) and 1% subtilin (B). X-fold induction was calculated 827 
relative to transcript levels in the same strain under reference conditions. Data are shown as mean 828 










Figure 6: Bacterial two-hybrid analysis of the interactions of DerB with the PsdRSAB module. C-837 
terminal and N-terminal translational fusions of the T18 and T25 domains of the adenylate cyclase 838 
CyaA of B. pertussis were created for each protein individually. Different hybrid fusions were 839 
tested in pairwise combinations in E. coli BTH101. The cells were spotted onto LB plates containing 840 
X-Gal (100 μg ml-1), IPTG (1 mM), and antibiotics for selection. Pictures were taken after 48 h of 841 
incubation at 30 °C. The blue colonies indicate positive interaction results. For clarity, only a single 842 
representative pair is shown in the figure. See Figure S6 for the complete set of combinations. 843 




Figure 7: Structure and sequence comparison of defensins grouped according to loop size and loop 846 
sequence similarity. A) Structural alignment of defensins. Substrates of DerAB transporter are 847 
colored blue and cyan, non-substrates are colored red and orange. B) Sequence alignment. Residues 848 
are colored according to conservation from 0% (red) to 100% (blue). The N-terminal loop and the 849 




DEFENSIN RESISTANCE IN L. CASEI, REVILLA-GUARINOS ET AL. 1 
 
The ABC transporter DerAB of Lactobacillus casei mediates resistance against 
eukaryotic defensins 
SUPPLEMENTAL MATERIAL 
Ainhoa Revilla-Guarinos 1,#, Qian Zhang 1, Christoph Loderer1, Cristina Alcántara 2, Ariane Müller3, 
Mohammad Rahnamaeian4, Andreas Vilcinskas4,5, Susanne Gebhard6, Manuel Zúñiga 2 and 
Thorsten Mascher 1,# 
 
1 Institut für Mikrobiologie, Technische Universität Dresden, Dresden, Germany 
2 Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), Valencia, Spain 
3 Institut für Zoologie, Technische Universität Dresden, Dresden, Germany 
4 Fraunhofer Institute for Molecular Biology and Applied Ecology, Department of Bioresources, 
Giessen, Germany 
5 Institute for Insect Biotechnology, Justus Liebig University Giessen, Giessen, Germany 
6 Department of Biology and Biochemistry, Milner Centre for Evolution, University of Bath, United 
Kingdom 
 
RUNNING TITLE: Defensin resistance in L. casei 
 
#Address correspondence to Ainhoa Revilla-Guarinos, ainhoa.revilla-guarinos@tu-dresden.de; or 
to Thorsten Mascher, thorsten.mascher@tu-dresden.de. 
 
KEY WORDS: cell envelope stress response, antimicrobial peptide resistance, ABC transporter, 






DEFENSIN RESISTANCE IN L. CASEI, REVILLA-GUARINOS ET AL. 2 
 
 
Supplemental Table 1. Quantification of the different sensitivity phenotypes of L. casei BL23 and 
∆derB strains after exposition to insect derived AMPs.  Stationary phase cell cultures of BL23 and 
∆derB grown for 24 hours under reference conditions or in the presence of insect derived AMPs 
were photographed (see Figure 3 in the main text). The bacterial length, cell-chain length and 
number of cells per chain values were measured for each strain under the reference and stress 
conditions.  Pairwise two-way ANOVA statistical analysis were applied to determine the contribution 
of the treatment and the strain to the morphological phenotypes (see Materials and methods in the 
main text for further details).  
 Strain ANOVAd 
Condition Phenotype BL23 ∆derB Cond. Strain Int. 
Reference 
conditions 
Bacterial length (µm) a, b 3,22 ± 1,00 3,30 ± 0,83    
Cell-chain length (µm) a, c 7,43 ± 2,74 9,92 ± 6,19    
Number of cells/chain a, c 2,25 ± 0,54 3,03 ± 1,39    
BR005 
320 µg/ml  
Bacterial length (µm) a, b 2,80 ± 0,68 2,69 ± 0,64 < 0,0001 0,8318 0,0929 
Cell-chain length (µm) a, c 6,82 ± 2,65 7,59 ± 3,12 0,0200 0,0100 0,1711 
Number of cells/chain a, c 2,45 ± 1,01 2,9 ± 1,15 0,8362 0,0004 0,3304 
BR090 
400 µg/ml 
Bacterial length (µm) a, b 2,85 ± 0,87 2,90 ± 1,10 < 0,0001 0,3104 0,8299 
Cell-chain length (µm) a, c  8,37 ± 4,22 21,1 ± 10,2 < 0,0001 < 0,0001 < 0,0001 
Number of cells/chain a, c 2,93 ±1,25 7,30 ± 3,55 < 0,0001 < 0,0001 < 0,0001 
BR080 
80 µg/ml 
Bacterial length (µm) a, b 3,07 ± 0,83 2,57 ± 0,86 < 0,0001 0,0008 < 0,0001 
Cell-chain length (µm) a, c 7,82 ± 3,13 30,6 ± 21,7 < 0,0001 < 0,0001 < 0,0001 
Number of cells/chain a, c 2,55 ± 0,90 11,4 ± 7,46 < 0,0001 < 0,0001 < 0,0001 
a The values represent means and standard deviations. b For bacterial length determination, n = 200 cells per 
condition; c for the determination of the cell-chain length and the number of cells per chain, n = 40 cell-chains 
per condition. d P values from pairwise two-way ANOVA analyses testing the growth of BL23 and derB mutant 
strain under the reference condition and in the presence of each of the three AMPs (BR005, BR090 and 
BR080) characterized microscopically in Figure 3. Significant differences (P value <0.01) are indicated in bold 
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Supplemental figure 1: MIC of LL37 for L. casei BL23 and derivative strains. Strains were inoculated 
from overnight cultures to an OD595 of 0.05 (grey dashed line) in MRS with different serial dilutions 
of LL37.  Final OD595 readings were taken after 15h incubation at 37°C (OD595 15h). MIC was defined 
at the lowest antibiotic concentration where the final OD was at or below the starting OD. Mean 
and standard deviation are presented. 
  
  
DEFENSIN RESISTANCE IN L. CASEI, REVILLA-GUARINOS ET AL. 4 
 
 
Supplemental figure 2: MIC of Sapecin A (BR080) (A) and Nisin (B) for C-derB (the ΔderB 
complemented strain). The L. casei BL23 and the ΔderB mutant strain are shown for comparison. 
Strains were inoculated to an OD595 of 0.05 (dashed line) in MRS with different concentrations of 
antibiotics. Final OD595 readings were taken after 15h incubation at 37°C (OD595 15h). MIC was 
defined at the lowest antibiotic concentration where the final OD was at or below the starting OD. 
Mean and standard deviation of triplicates are presented. Different stock solutions of nisin (Sigma-
Aldrich N5764: Nisin from Lactococcus lactis 2.5% (balance sodium chloride and denature milk 
solids)) and sapecin A (chemically synthetized by Covalab S.A.S., Villeurbanne, France for the 
experiments presented in Figure 2 and by Panatecs® Heilbronn, Germany for the experiments 
presented in Sup. Fig. 2) might account for the different MIC values observed for strain BL23 and 
ΔderB mutant on Figure 2 and Sup. Fig. 2. Notwithstanding, the overall relative sensitivities were 
very well reproduced. 
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Supplemental figure 3: Cytochrome c (cyt c) binding in stationary phase. Binding is expressed as 
the percentage of cyt c bound to stationary-phase cells of strain BL23 and ΔderB after incubation 
with 150 µg ml-1 cyt c for 10 min at room temperature. Data represent the means and standard 
deviations from three independent experiments. Unpaired Student t test showed no significant 
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Supplemental figure 4: Microscopy of L. casei BL23 and derivative strain ΔderB after exposition to 
H. illucens extract. Stationary phase cell cultures of BL23 (left column) and ΔderB (right column) 
grown for 24 hours under reference conditions (top pictures) or in the presence H. illucens extract 
(bottom pictures) were photographed (phase contrast, 40x magnification). Due to the different 
sensitivities’ phenotypes of wild type and mutant strain (See Fig. 2G in the main text), the pictures 
were made after exposition to a concentration of the extract of 2.5 % (v/v) for the wild type and 
0.02 % (v/v) for the mutant. Scale bar 20 µm. 
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Supplemental figure 5: Expression of known nisin and subtilin resistance determinants in ΔderB 
mutant background. Transcript levels were determined by real-time RT-PCR in reference conditions, 
10 min after addition of 22.5 ng ml-1 nisin and 10 min after addition of 1% subtilin. X-fold induction 
of known nisin and subtilin resistance genes in ΔderB strain were calculated relative to transcript 
levels in the parental strain L. casei BL23 under the same conditions. Data are shown as mean ± 










Supplemental figure 6: Complete data set 
for the bacterial two-hybrid analysis. The 
interactions of DerAB proteins with the 
PsdRSAB module proteins are shown in the 
four panels in (A) and the interactions of 
DerAB proteins with the ApsRSAB module 
proteins in the four panels in (B).  
C-terminal and N-terminal translational 
fusions of the T18 and T25 domains of CyaA 
of B. pertussis were created for each 
protein individually. The expression vectors 
are indicated in the y and x axis.  
pKT25 and pKNT25 both encode the T25 
fragment (first 224 aminoacids of CyaA), 
they are low-copy number plasmids 
expressing kanamycin resistance. pKT25 
allows in-frame fusions at the C-terminal 
end of the T25 polypeptide 
(T25 - protein of interest); pKNT25 allows 
in-frame fusions at the N-terminal end of 
T25 (protein of interest - T25).  
pUT18 and pUT18C both encode the T18 
fragment (amino acids 225 to 399 of CyaA), 
they are high copy number plasmids 
expressing ampicillin resistance. pUT18 
allows in-frame fusions at the N-terminal 
end of T18 (protein of interest - T18); 
pUT18C allows in-frame fusions at the C-
terminal end of the T18 
(T18 – protein of interest). 
The plasmids pKT25-zip and pUT18C-zip 
served as positive controls for 
complementation (shown as "+") and 
vectors pKT25 and pUT18C as negative 
controls (shown as "-"). 
Different hybrid fusions were tested in 
pairwise combinations in E. coli BTH101. 
The cells were spotted onto LB plates 
containing X-Gal (100 μg ml-1), IPTG (1 mM), 
and antibiotics for selection. Pictures were 
taken after 48 h of incubation at 30 °C. The 
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Supplemental figure 7: Sequence identity matrix of the defensins under study. Text color code 
indicates if both (bold green), one (bold black) or none (bold red) of the compared defensins are 
substrates of the DerAB transporter. Comparison between two defensins from the same group 
shown in Supplemental figure 7 are highlighted with background colors: group I- pink; group II- 
yellow; group III- blue. The identity values (indicated as a %) were obtained after sequence 
comparison of the defensins with Protein BLAST program (https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
n.a. not available.  
 
 
